Fennec Pharma Revenue, Profits - FENC Annual Income Statement

Add to My Stocks
$8.17 $0.06 (0.73%) FENC stock closing price Sep 20, 2018 (Closing)

Financial analysis of Fennec Pharma involves more than just checking the Fennec Pharma stock price, by looking at the financial statements of the company in detail. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. Like any other income statement, the FENC income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue decline of 0 when compared to the same period in the past. Along with Fennec Pharma assets and Fennec Pharma free cash flow, Fennec Pharma profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $-7.04M and the 2017 revenue is $-.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Fennec Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Fennec Pharma Gross Profit
Research & Development Expense1.93M----2.07M1.49M-2.11M10.36M
Selling General & Admin Expense5.01M2.39M1.63M2.52M1.33M1.54M1.94M3.89M1.1M3.52M
Income Before Depreciation Depletion Amortization-6.95M-2.87M-1.89M-2.87M-1.93M-3.62M-3.43M-4.6M-3.21M-13.88M
Depreciation Depletion Amortization----------
Non Operating Income-0.09M-1.23M-3.77M-1.54M8.12M-3.21M--
Interest Expense----------
Fennec Pharma Pretax Income
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-7.04M-2.78M-0.65M-2.17M1.84M-5.16M4.68M-7.82M-3.01M-13.6M
Extraordinary Items & Discontinued Operations----------
Fennec Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS14.99M12.68M10.98M9.89M10.25M8.19M-5.34M2.79M-
Average Shares used to compute Basic EPS14.99M12.68M10.98M9.89M10.25M8.19M-5.34M2.79M-
Income Before Nonrecurring Items-7.05M-2.79M-1.46M-2.18M-1.93M-3.6M--7.82M-2.63M-
Income from Nonrecurring Items----3.78M-1.56M---0.39M-
Fennec Pharma Earnings Per Share Basic Net
Fennec Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.47-0.22-0.13-0.22-0.18-0.45--1.62-1.08-
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

It is very helpful to read a report on Fennec Pharma stock analysis. An investor must check the following items in an income statement:

  • Topline: A growing topline, as seen from the Fennec Pharma revenue chart, as isn't the case with Fennec Pharma indicates a sagging business. One needs to compare the YoY topline or sales growth of FENC stock with its peers like EMIS stock and ADMP stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. FENC stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the FENC income statement, one can check the Fennec Pharma historical stock prices to check how the price has moved with time.

Fennec Pharma Income Statement - Key Financial Ratios